Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Coates

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Pharmacoeconomics|April 4, 2007
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspectiveThomas E Delea, Oleg Sofrygin, Simu K Thomas, et al.
American Journal of Hematology|January 21, 2020
Aura and mental stress are associated with reports of pain in sickle cell disease-a pilot study using a mobile applicationJuan Espinoza, Payal Shah, Saranya Veluswamy, et al.
Blood|April 30, 2005
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patientsJohn C Wood, Cathleen Enriquez, Nilesh Ghugre, et al.
American Journal of Hematology|May 31, 2024
Moderate-severe beta-thalassemia intermedia phenotype caused by sextuplicated alpha-globin gene allele in two beta-thalassemia carriersAhlem Achour, Jeroen Knijnenburg, Tamara Koopmann, et al.
Blood|July 24, 2024
Significant pituitary siderosis is common in transfusion-dependent sickle cell diseaseAkhila Vadivelan, Eamon K Doyle, Susan Carson, et al.
American Journal of Hematology|January 4, 2012
Pituitary iron and volume predict hypogonadism in transfusional iron overloadLeila J Noetzli, Ashok Panigrahy, Steven D Mittelman, et al.
Blood|July 20, 2022
Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemiaOmar Niss, Jon Detterich, John C Wood, et al.
Pediatric Blood & Cancer|September 2, 2014
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)Susan T Paulukonis, William T Harris, Thomas D Coates, et al.
American Journal of Hematology|May 6, 2009
Nutritional deficiencies in iron overloaded patients with hemoglobinopathiesSusan Claster, John C Wood, Leila Noetzli, et al.
British Journal of Haematology|August 25, 2021
Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety projectSherif M Badawy, Amanda B Payne, Mary M Hulihan, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Pharmacoeconomics|April 4, 2007
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspectiveThomas E Delea, Oleg Sofrygin, Simu K Thomas, et al.
American Journal of Hematology|January 21, 2020
Aura and mental stress are associated with reports of pain in sickle cell disease-a pilot study using a mobile applicationJuan Espinoza, Payal Shah, Saranya Veluswamy, et al.
Blood|April 30, 2005
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patientsJohn C Wood, Cathleen Enriquez, Nilesh Ghugre, et al.
American Journal of Hematology|May 31, 2024
Moderate-severe beta-thalassemia intermedia phenotype caused by sextuplicated alpha-globin gene allele in two beta-thalassemia carriersAhlem Achour, Jeroen Knijnenburg, Tamara Koopmann, et al.
Blood|July 24, 2024
Significant pituitary siderosis is common in transfusion-dependent sickle cell diseaseAkhila Vadivelan, Eamon K Doyle, Susan Carson, et al.
American Journal of Hematology|January 4, 2012
Pituitary iron and volume predict hypogonadism in transfusional iron overloadLeila J Noetzli, Ashok Panigrahy, Steven D Mittelman, et al.
Blood|July 20, 2022
Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemiaOmar Niss, Jon Detterich, John C Wood, et al.
Pediatric Blood & Cancer|September 2, 2014
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)Susan T Paulukonis, William T Harris, Thomas D Coates, et al.
American Journal of Hematology|May 6, 2009
Nutritional deficiencies in iron overloaded patients with hemoglobinopathiesSusan Claster, John C Wood, Leila Noetzli, et al.
British Journal of Haematology|August 25, 2021
Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety projectSherif M Badawy, Amanda B Payne, Mary M Hulihan, et al.
Pageof 15